TargetFibroblast growth factor receptor 3(Homo sapiens (Human))
Bayer Intellectual Property GmbH
US Patent
Bayer Intellectual Property GmbH
US Patent
TargetFibroblast growth factor receptor 3(Homo sapiens (Human))
Bayer Intellectual Property GmbH
US Patent
Bayer Intellectual Property GmbH
US Patent
TargetFibroblast growth factor receptor 1(Homo sapiens (Human))
Bayer Intellectual Property GmbH
US Patent
Bayer Intellectual Property GmbH
US Patent
Affinity DataIC50: 0.200nMAssay Description:Usually, test compounds were tested on the same microtiter plate at 11 different concentrations in the range of 20 μM to 0.1 nM (e.g. 20 μM...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 3(Homo sapiens (Human))
Bayer Intellectual Property GmbH
US Patent
Bayer Intellectual Property GmbH
US Patent
TargetFibroblast growth factor receptor 1(Homo sapiens (Human))
Bayer Intellectual Property GmbH
US Patent
Bayer Intellectual Property GmbH
US Patent
Affinity DataIC50: 0.300nMAssay Description:Usually, test compounds were tested on the same microtiter plate at 11 different concentrations in the range of 20 μM to 0.1 nM (e.g. 20 μM...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 3(Homo sapiens (Human))
Bayer Intellectual Property GmbH
US Patent
Bayer Intellectual Property GmbH
US Patent
TargetFibroblast growth factor receptor 3(Homo sapiens (Human))
Bayer Intellectual Property GmbH
US Patent
Bayer Intellectual Property GmbH
US Patent
TargetFibroblast growth factor receptor 3(Homo sapiens (Human))
Bayer Intellectual Property GmbH
US Patent
Bayer Intellectual Property GmbH
US Patent
TargetFibroblast growth factor receptor 3(Homo sapiens (Human))
Bayer Intellectual Property GmbH
US Patent
Bayer Intellectual Property GmbH
US Patent
TargetFibroblast growth factor receptor 3(Homo sapiens (Human))
Bayer Intellectual Property GmbH
US Patent
Bayer Intellectual Property GmbH
US Patent
TargetFibroblast growth factor receptor 1(Homo sapiens (Human))
Bayer Intellectual Property GmbH
US Patent
Bayer Intellectual Property GmbH
US Patent
Affinity DataIC50: 0.600nMAssay Description:Usually, test compounds were tested on the same microtiter plate at 11 different concentrations in the range of 20 μM to 0.1 nM (e.g. 20 μM...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 1(Homo sapiens (Human))
Bayer Intellectual Property GmbH
US Patent
Bayer Intellectual Property GmbH
US Patent
Affinity DataIC50: 0.600nMAssay Description:Usually, test compounds were tested on the same microtiter plate at 11 different concentrations in the range of 20 μM to 0.1 nM (e.g. 20 μM...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 3(Homo sapiens (Human))
Bayer Intellectual Property GmbH
US Patent
Bayer Intellectual Property GmbH
US Patent
TargetFibroblast growth factor receptor 3(Homo sapiens (Human))
Bayer Intellectual Property GmbH
US Patent
Bayer Intellectual Property GmbH
US Patent
TargetFibroblast growth factor receptor 1(Homo sapiens (Human))
Bayer Intellectual Property GmbH
US Patent
Bayer Intellectual Property GmbH
US Patent
Affinity DataIC50: 0.700nMAssay Description:Usually, test compounds were tested on the same microtiter plate at 11 different concentrations in the range of 20 μM to 0.1 nM (e.g. 20 μM...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 3(Homo sapiens (Human))
Bayer Intellectual Property GmbH
US Patent
Bayer Intellectual Property GmbH
US Patent
TargetFibroblast growth factor receptor 1(Homo sapiens (Human))
Bayer Intellectual Property GmbH
US Patent
Bayer Intellectual Property GmbH
US Patent
Affinity DataIC50: 0.700nMAssay Description:Usually, test compounds were tested on the same microtiter plate at 11 different concentrations in the range of 20 μM to 0.1 nM (e.g. 20 μM...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 3(Homo sapiens (Human))
Bayer Intellectual Property GmbH
US Patent
Bayer Intellectual Property GmbH
US Patent
TargetFibroblast growth factor receptor 3(Homo sapiens (Human))
Bayer Intellectual Property GmbH
US Patent
Bayer Intellectual Property GmbH
US Patent
TargetFibroblast growth factor receptor 1(Homo sapiens (Human))
Bayer Intellectual Property GmbH
US Patent
Bayer Intellectual Property GmbH
US Patent
Affinity DataIC50: 0.900nMAssay Description:Usually, test compounds were tested on the same microtiter plate at 11 different concentrations in the range of 20 μM to 0.1 nM (e.g. 20 μM...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 1(Homo sapiens (Human))
Bayer Intellectual Property GmbH
US Patent
Bayer Intellectual Property GmbH
US Patent
Affinity DataIC50: 0.900nMAssay Description:Usually, test compounds were tested on the same microtiter plate at 11 different concentrations in the range of 20 μM to 0.1 nM (e.g. 20 μM...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 1(Homo sapiens (Human))
Bayer Intellectual Property GmbH
US Patent
Bayer Intellectual Property GmbH
US Patent
Affinity DataIC50: 1nMAssay Description:Usually, test compounds were tested on the same microtiter plate at 11 different concentrations in the range of 20 μM to 0.1 nM (e.g. 20 μM...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 1(Homo sapiens (Human))
Bayer Intellectual Property GmbH
US Patent
Bayer Intellectual Property GmbH
US Patent
Affinity DataIC50: 1nMAssay Description:Usually, test compounds were tested on the same microtiter plate at 11 different concentrations in the range of 20 μM to 0.1 nM (e.g. 20 μM...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 3(Homo sapiens (Human))
Bayer Intellectual Property GmbH
US Patent
Bayer Intellectual Property GmbH
US Patent
TargetFibroblast growth factor receptor 1(Homo sapiens (Human))
Bayer Intellectual Property GmbH
US Patent
Bayer Intellectual Property GmbH
US Patent
Affinity DataIC50: 1.10nMAssay Description:Usually, test compounds were tested on the same microtiter plate at 11 different concentrations in the range of 20 μM to 0.1 nM (e.g. 20 μM...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 3(Homo sapiens (Human))
Bayer Intellectual Property GmbH
US Patent
Bayer Intellectual Property GmbH
US Patent
TargetFibroblast growth factor receptor 3(Homo sapiens (Human))
Bayer Intellectual Property GmbH
US Patent
Bayer Intellectual Property GmbH
US Patent
TargetFibroblast growth factor receptor 3(Homo sapiens (Human))
Bayer Intellectual Property GmbH
US Patent
Bayer Intellectual Property GmbH
US Patent
TargetFibroblast growth factor receptor 1(Homo sapiens (Human))
Bayer Intellectual Property GmbH
US Patent
Bayer Intellectual Property GmbH
US Patent
Affinity DataIC50: 1.30nMAssay Description:Usually, test compounds were tested on the same microtiter plate at 11 different concentrations in the range of 20 μM to 0.1 nM (e.g. 20 μM...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 1(Homo sapiens (Human))
Bayer Intellectual Property GmbH
US Patent
Bayer Intellectual Property GmbH
US Patent
Affinity DataIC50: 1.40nMAssay Description:Usually, test compounds were tested on the same microtiter plate at 11 different concentrations in the range of 20 μM to 0.1 nM (e.g. 20 μM...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 3(Homo sapiens (Human))
Bayer Intellectual Property GmbH
US Patent
Bayer Intellectual Property GmbH
US Patent
TargetFibroblast growth factor receptor 3(Homo sapiens (Human))
Bayer Intellectual Property GmbH
US Patent
Bayer Intellectual Property GmbH
US Patent
TargetFibroblast growth factor receptor 1(Homo sapiens (Human))
Bayer Intellectual Property GmbH
US Patent
Bayer Intellectual Property GmbH
US Patent
Affinity DataIC50: 1.5nMAssay Description:Usually, test compounds were tested on the same microtiter plate at 11 different concentrations in the range of 20 μM to 0.1 nM (e.g. 20 μM...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 1(Homo sapiens (Human))
Bayer Intellectual Property GmbH
US Patent
Bayer Intellectual Property GmbH
US Patent
Affinity DataIC50: 1.60nMAssay Description:Usually, test compounds were tested on the same microtiter plate at 11 different concentrations in the range of 20 μM to 0.1 nM (e.g. 20 μM...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 1(Homo sapiens (Human))
Bayer Intellectual Property GmbH
US Patent
Bayer Intellectual Property GmbH
US Patent
Affinity DataIC50: 1.60nMAssay Description:Usually, test compounds were tested on the same microtiter plate at 11 different concentrations in the range of 20 μM to 0.1 nM (e.g. 20 μM...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 1(Homo sapiens (Human))
Bayer Intellectual Property GmbH
US Patent
Bayer Intellectual Property GmbH
US Patent
Affinity DataIC50: 1.70nMAssay Description:Usually, test compounds were tested on the same microtiter plate at 11 different concentrations in the range of 20 μM to 0.1 nM (e.g. 20 μM...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 1(Homo sapiens (Human))
Bayer Intellectual Property GmbH
US Patent
Bayer Intellectual Property GmbH
US Patent
Affinity DataIC50: 1.80nMAssay Description:Usually, test compounds were tested on the same microtiter plate at 11 different concentrations in the range of 20 μM to 0.1 nM (e.g. 20 μM...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 3(Homo sapiens (Human))
Bayer Intellectual Property GmbH
US Patent
Bayer Intellectual Property GmbH
US Patent
TargetFibroblast growth factor receptor 3(Homo sapiens (Human))
Bayer Intellectual Property GmbH
US Patent
Bayer Intellectual Property GmbH
US Patent
TargetFibroblast growth factor receptor 1(Homo sapiens (Human))
Bayer Intellectual Property GmbH
US Patent
Bayer Intellectual Property GmbH
US Patent
Affinity DataIC50: 2nMAssay Description:Usually, test compounds were tested on the same microtiter plate at 11 different concentrations in the range of 20 μM to 0.1 nM (e.g. 20 μM...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 3(Homo sapiens (Human))
Bayer Intellectual Property GmbH
US Patent
Bayer Intellectual Property GmbH
US Patent
TargetFibroblast growth factor receptor 1(Homo sapiens (Human))
Bayer Intellectual Property GmbH
US Patent
Bayer Intellectual Property GmbH
US Patent
Affinity DataIC50: 2nMAssay Description:Usually, test compounds were tested on the same microtiter plate at 11 different concentrations in the range of 20 μM to 0.1 nM (e.g. 20 μM...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 1(Homo sapiens (Human))
Bayer Intellectual Property GmbH
US Patent
Bayer Intellectual Property GmbH
US Patent
Affinity DataIC50: 2.20nMAssay Description:Usually, test compounds were tested on the same microtiter plate at 11 different concentrations in the range of 20 μM to 0.1 nM (e.g. 20 μM...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 3(Homo sapiens (Human))
Bayer Intellectual Property GmbH
US Patent
Bayer Intellectual Property GmbH
US Patent
TargetFibroblast growth factor receptor 3(Homo sapiens (Human))
Bayer Intellectual Property GmbH
US Patent
Bayer Intellectual Property GmbH
US Patent
TargetFibroblast growth factor receptor 3(Homo sapiens (Human))
Bayer Intellectual Property GmbH
US Patent
Bayer Intellectual Property GmbH
US Patent
TargetFibroblast growth factor receptor 3(Homo sapiens (Human))
Bayer Intellectual Property GmbH
US Patent
Bayer Intellectual Property GmbH
US Patent
TargetFibroblast growth factor receptor 1(Homo sapiens (Human))
Bayer Intellectual Property GmbH
US Patent
Bayer Intellectual Property GmbH
US Patent
Affinity DataIC50: 2.5nMAssay Description:Usually, test compounds were tested on the same microtiter plate at 11 different concentrations in the range of 20 μM to 0.1 nM (e.g. 20 μM...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 3(Homo sapiens (Human))
Bayer Intellectual Property GmbH
US Patent
Bayer Intellectual Property GmbH
US Patent
TargetFibroblast growth factor receptor 3(Homo sapiens (Human))
Bayer Intellectual Property GmbH
US Patent
Bayer Intellectual Property GmbH
US Patent
